Ligand Pharmaceuticals Incorporated Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count |
|---|---|---|---|---|
AKRO
Akero Therapeutics, Inc. |
$49.65 | $3.96 B | -13.24 | 69 |
ASND
Ascendis Pharma A/S |
$162.84 | $9.83 B | -24.71 | 1017 |
CGEM
Cullinan Oncology, Inc. |
$8.65 | $509.30 M | -3.12 | 111 |
LYEL
Lyell Immunopharma, Inc. |
$0.44 | $118.93 M | -0.32 | 300 |
ETNB
89bio, Inc. |
$9.84 | $1.44 B | -2.84 | 93 |
GPCR
Structure Therapeutics Inc. |
$21.76 | $429.22 M | -8.67 | 163 |
ANNX
Annexon, Inc. |
$2.04 | $224.37 M | -1.75 | 106 |
CYTK
Cytokinetics, Incorporated |
$31.02 | $3.70 B | -5.67 | 498 |
ICVX
Icosavax, Inc. |
$0.00 | $769.04 M | -6.96 | 60 |
VRDN
Viridian Therapeutics, Inc. |
$13.92 | $1.14 B | -4.3 | 143 |
PASG
Passage Bio, Inc. |
$0.44 | $28.36 M | -0.45 | 60 |
BPMC
Blueprint Medicines Corporation |
$101.35 | $6.54 B | -37.38 | 682 |
CRNX
Crinetics Pharmaceuticals, Inc. |
$30.51 | $2.86 B | -8.02 | 437 |
RLAY
Relay Therapeutics, Inc. |
$3.00 | $527.19 M | -1.4 | 259 |
BGNE
BeiGene, Ltd. |
$245.58 | $20.21 B | -22.55 | 10600 |
DSGN
Design Therapeutics, Inc. |
$3.73 | $212.03 M | -3.77 | 56 |
TERN
Terns Pharmaceuticals, Inc. |
$3.11 | $270.75 M | -2.87 | 59 |
ORIC
ORIC Pharmaceuticals, Inc. |
$8.17 | $566.22 M | -4.24 | 122 |
APLS
Apellis Pharmaceuticals, Inc. |
$16.93 | $2.13 B | -9.1 | 705 |
RCUS
Arcus Biosciences, Inc. |
$8.92 | $943.96 M | -2.11 | 627 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
